1-8 of 8
Mark Bennett
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Estimation of Relapsed/Refractory Follicular Lymphoma Patients on Therapy in the United States

Karissa Johnston, Mark Bennett, Savreet Bains Chawla, Shibing Yang, Anthony Wang, Junhua Yu, Monika Jun
Journal: Blood
Blood (2023) 142 (Supplement 1): 6148.
https://doi.org/10.1182/blood-2023-182030
Published: 2023
Journal Articles

Phase 1 Study of CB-839, a First-in-Class, Orally Administered Small Molecule Inhibitor of Glutaminase in Patients with Relapsed/Refractory Leukemia

Eunice S. Wang, MD, Olga Frankfurt, MD, Keith William Orford, MD PhD, Mark Bennett, PhD, Ian W. Flinn, MD PhD, Michael Maris, MD, Marina Konopleva, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2566.
https://doi.org/10.1182/blood.V126.23.2566.2566
Published: 2015
Journal Articles

Metabolomic, Proteomic and Genomic Profiling Identifies Biomarakers of Sensitivity to Glutaminase Inhibitor CB-839 in Multiple Myeloma

Andrew L MacKinnon, PhD, Mark Bennett, PhD, Matt Gross, B.S., Julie Janes, M.S., Weiqin Li, PhD, Mirna Rodriquez, B.S., Tracy Wang, BS, Winter Zhang, B.S., Francesco Parlati, PhD
Journal: Blood
Blood (2015) 126 (23): 1802.
https://doi.org/10.1182/blood.V126.23.1802.1802
Published: 2015
Journal Articles

Phase 1 Study of CB-839, a First-in-Class, Glutaminase Inhibitor in Patients with Multiple Myeloma and Lymphoma

Dan T. Vogl, MD, Anas Younes, MD, Keith Stewart, MD, Keith William Orford, MD PhD, Mark Bennett, PhD, David Siegel, MD PhD, Jesus G. Berdeja, MD
Journal: Blood
Blood (2015) 126 (23): 3059.
https://doi.org/10.1182/blood.V126.23.3059.3059
Published: 2015
Journal Articles

Glutaminase Inhibitor CB-839 Synergizes with Pomalidomide in Preclinical Multiple Myeloma Models

Francesco Parlati, PhD, Mathew Gross, BS, Julie Janes, MS, Evan Lewis, PhD, Andy MacKinnon, PhD, Mirna Rodriguez, BS, Peter Shwonek, BS, Mark Bennett, PhD
Journal: Blood
Blood (2014) 124 (21): 4720.
https://doi.org/10.1182/blood.V124.21.4720.4720
Published: 2014
Journal Articles

Biomarkers of Response to the Glutaminase Inhibitor CB-839 in Multiple Myeloma Cells

Andrew Mackinnon, PhD, Mark Bennett, PhD, Mirna Rodriguez, BS, Francesco Parlati, PhD
Journal: Blood
Blood (2014) 124 (21): 3429.
https://doi.org/10.1182/blood.V124.21.3429.3429
Published: 2014
Journal Articles

Antitumor Activity Of The Glutaminase Inhibitor CB-839 In Hematological Malignances

Francesco Parlati, PhD, Shoshana Bromley-Dulfano, BS, Susan Demo, PhD, Julie Janes, MS, Matt Gross, BS, Evan Lewis, PhD, Andy MacKinnon, PhD, Mirna Rodriguez, BS, Jinfu Yang, PhD, Frances Zhao, MS, Mark Bennett, PhD
Journal: Blood
Blood (2013) 122 (21): 4226.
https://doi.org/10.1182/blood.V122.21.4226.4226
Published: 2013
Journal Articles

Anti-Tumor Activity of Immunoproteasome Selective Inhibitors.

Francesco Parlati, Monette Aujay, Siv Lise Bedringaas, Susan Demo, Bjorn Gjertsen, Eileen Goldstein, Jing Jiang, Christopher Kirk, Guy Laidig, James Lorens, Yan Lu, David Micklem, Paulina Ruurs, Kevin Shenk, Catherine Sylvain, Congcong Sun, Tina Woo, Han-Jie Zhou, Mark Bennett
Journal: Blood
Blood (2007) 110 (11): 1599.
https://doi.org/10.1182/blood.V110.11.1599.1599
Published: 2007